Jiangsu Hengrui Pharmaceuticals Co.,Ltd (JHPCY)

Market Cap	53.81B +32.0%
Revenue (ttm)	4.35B +19.2%
Net Income	1.05B +37.1%
EPS	0.16 +34.9%
Shares Out	n/a
PE Ratio	51.30
Forward PE	37.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	226
Average Volume	n/a
Open	16.72
Previous Close	n/a
Day's Range	16.72 - 16.72
52-Week Range	16.72 - 16.72
Beta	n/a
RSI	n/a
Earnings Date	Mar 25, 2026

About JHPCY

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

• Industry: Pharmaceutical Preparations
• Founded: 1970
• Employees: 20,238
• Stock Exchange: OTCMKTS
• Ticker Symbol: JHPCY